Efficacy and Safety of 611 in Chinese Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Phase II Trial

Yan Zhao(Shanghai Ocean University), Jianzhong Zhang(Chinese Academy of Sciences), Jianjian Zhu(National Cancer Institute), Bin Yang(Southern Medical University), Lunfei Liu, Xinsuo Duan(Affiliated Hospital of Chengde Medical College), Haomin Huang(South China University of Technology), Rong Xiao(Tongji University), Qinghong Zhou(Beijing University of Chinese Medicine), Liming Wu(Hangzhou First People's Hospital), Mingkai Ji, Yuyu Xu(Qilu University of Technology), Yanyan Feng(Shanghai Jiao Tong University), Litao Zhang(Tianjin University of Traditional Chinese Medicine), Jianguo Li(Henan Provincial People's Hospital), Chao Ji(Zhongshan Hospital of Xiamen University), Yangfeng Ding(Shanghai Skin Disease Hospital), Guohong Hu(Shanghai Jiao Tong University)
Dermatology and Therapy
March 9, 2025
Cited by 2


Related Papers